Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Scilex Holding Co. (SCLX)

Scilex Holding Co. (SCLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Scilex Holding Company Announces Early Repayment of $13.2 Million Under Oramed Note

Scilex Holding Company announces a $13.2 million early payment on its Oramed Note, reducing remaining balance due March 2025.Quiver AI SummaryScilex Holding Company, based in Palo Alto, California, has...

SCLX : 0.4475 (+1.64%)
Scilex Holding Company Announces Early Installment Payment on its Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation

SCLX : 0.4475 (+1.64%)
Scilex Holding Company Closes Registered Direct Offering, Raising Approximately $17 Million

Scilex Holding Company closed a direct stock offering, raising approximately $17 million for corporate purposes and product development.Quiver AI SummaryScilex Holding Company has successfully closed a...

SCLX : 0.4475 (+1.64%)
Scilex Holding Company Announces Closing of $17 Million Registered Direct Offering

SCLX : 0.4475 (+1.64%)
Scilex Holding Company Announces Agreement for Sale of Common Stock and Warrants, Expected Gross Proceeds of $17 Million

Scilex Holding Company announces a $17 million stock offering for growth and development in pain management therapies.Quiver AI SummaryScilex Holding Company announced a definitive agreement with institutional...

SCLX : 0.4475 (+1.64%)
Scilex Holding Company Announces $17 Million Registered Direct Offering

SCLX : 0.4475 (+1.64%)
Scilex Bio Announces Ongoing Phase 2 Trial for KDS2010 in Obesity Treatment, Expanding to U.S. in 2025

KDS2010 Phase 2 trial evaluates safety and efficacy for obesity treatment; positive Phase 1 results reported.Quiver AI SummaryScilex Bio has announced an ongoing Phase 2 clinical trial for KDS2010, a novel...

SCLX : 0.4475 (+1.64%)
Scilex Bio, a Controlling Interest of Joint Venture by Scilex Holding Company, Reports KDS2010 a Novel Oral Tablet Phase 2 Trial for Alzheimer’s Disease (AD) Currently Enrolling with U.S. Patient Cohort to be Added in 2025

SCLX : 0.4475 (+1.64%)
Scilex Bio, a Controlling Interest of Joint Venture by Scilex Holding Company, Reports Phase 2 Trial for Obesity Currently Enrolling with U.S. Patient Cohort to be Added in 2025. Scilex Bio Reports Positive Results from the Recently Completed...

SCLX : 0.4475 (+1.64%)
NeuroBiogen Company and Scilex Bio, a Controlling Interest of Joint Venture by Scilex Holding Company enter into Binding Term Sheet for Worldwide License, Along with the Rights to Sublicense for All of KDS2010 indications; Binding Term Sheet...

SCLX : 0.4475 (+1.64%)

Barchart Exclusives

Is It Time to Sell This Second-Fiddle AI Stock Before 2025?
Bank of America has cut its rating on AMD while lowering its price target. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar